Zachary Sun, CEO of Tierra Biosciences.
Zachary Sun has been developing fundamental synthetic biology technologies since 2006, and has published work on MAGE genomic engineering in Nature and on a cell-free prototyping environment in eLife. The latter forms the basis for Tierra Biosciences (formerly Synvitrobio). Sun is a NDSEG Fellow, a DARPA Rising participant, and part of the UCLA/Caltech NIH Medical Scientist Training Program. He holds a PhD in biology from Caltech, an AB in chemical and physical biology with high honors from Harvard, and is a MD candidate (on leave) from UCLA.